← All organizations

Sigilon Therapeutics, Inc.

For profitWebsite ↗

Also known as: Sigilon Therapeutics, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Nov 15, 2021

Acquired by Eli Lilly on Aug 14, 2023

Timeline

2010s

Jun 1, 2015
Sigilon Therapeutics, Inc.— Founded

2020s

Aug 14, 2023
Eli Lilly— Acquired By

Drugs by trial phase (2 distinct, 2 trials)

Phase 2 (2 own, 0 via acquisition)

Indications

Studied for

Hemophilia A

Recent trials (2)

NCT05665036Lead sponsorPhase 1/Phase 2Nov 15, 2021
NCT04541628Lead sponsorPhase 1/Phase 2Sep 28, 2020

Details

Founded: Cambridge, MA, US Jun 1, 2015
Last known activity: Nov 15, 2021